MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $906,934 | -30.8% | 56,542 | -0.0% | 0.00% | -33.3% |
| Q2 2023 | $1,310,667 | -3.2% | 56,543 | -3.0% | 0.00% | 0.0% |
| Q1 2023 | $1,353,868 | +65.1% | 58,281 | +3.2% | 0.00% | +50.0% |
| Q4 2022 | $819,815 | -22.5% | 56,500 | +1.9% | 0.00% | -33.3% |
| Q3 2022 | $1,058,000 | -24.6% | 55,453 | -28.2% | 0.00% | -25.0% |
| Q2 2022 | $1,403,000 | -50.2% | 77,215 | -30.9% | 0.00% | -33.3% |
| Q1 2022 | $2,817,000 | -16.6% | 111,782 | -8.6% | 0.01% | 0.0% |
| Q4 2021 | $3,376,000 | +12.7% | 122,329 | +31.8% | 0.01% | 0.0% |
| Q3 2021 | $2,996,000 | +50.3% | 92,795 | +42.4% | 0.01% | +50.0% |
| Q2 2021 | $1,993,000 | +0.1% | 65,168 | -0.4% | 0.00% | 0.0% |
| Q1 2021 | $1,992,000 | +39.5% | 65,427 | -9.4% | 0.00% | +33.3% |
| Q4 2020 | $1,428,000 | -85.4% | 72,235 | -90.4% | 0.00% | -87.0% |
| Q3 2020 | $9,806,000 | -36.5% | 751,983 | -44.8% | 0.02% | -39.5% |
| Q2 2020 | $15,439,000 | +38.8% | 1,361,424 | +75.2% | 0.04% | +15.2% |
| Q1 2020 | $11,122,000 | +227.9% | 777,205 | +536.6% | 0.03% | +312.5% |
| Q2 2019 | $3,392,000 | +22.3% | 122,085 | +46.2% | 0.01% | +14.3% |
| Q1 2019 | $2,773,000 | -22.3% | 83,515 | -32.0% | 0.01% | -30.0% |
| Q4 2018 | $3,568,000 | -66.0% | 122,727 | -46.2% | 0.01% | -58.3% |
| Q3 2018 | $10,484,000 | +32.4% | 227,919 | +7.5% | 0.02% | +4.3% |
| Q2 2018 | $7,920,000 | +178.8% | 211,926 | +120.4% | 0.02% | +187.5% |
| Q1 2018 | $2,841,000 | +2154.8% | 96,142 | +2524.0% | 0.01% | – |
| Q4 2017 | $126,000 | -5.3% | 3,664 | 0.0% | 0.00% | – |
| Q3 2017 | $133,000 | +37.1% | 3,664 | -2.0% | 0.00% | – |
| Q2 2017 | $97,000 | +34.7% | 3,739 | 0.0% | 0.00% | – |
| Q1 2017 | $72,000 | +16.1% | 3,739 | 0.0% | 0.00% | – |
| Q4 2016 | $62,000 | -20.5% | 3,739 | -1.7% | 0.00% | – |
| Q3 2016 | $78,000 | -32.8% | 3,805 | 0.0% | 0.00% | – |
| Q2 2016 | $116,000 | -79.5% | 3,805 | -74.8% | 0.00% | -100.0% |
| Q1 2016 | $565,000 | +250.9% | 15,096 | +304.7% | 0.00% | +100.0% |
| Q4 2015 | $161,000 | +15.0% | 3,730 | +0.1% | 0.00% | – |
| Q3 2015 | $140,000 | -77.8% | 3,728 | -79.9% | 0.00% | -100.0% |
| Q2 2015 | $630,000 | +180.0% | 18,542 | +191.9% | 0.00% | +100.0% |
| Q1 2015 | $225,000 | -85.9% | 6,353 | -86.5% | 0.00% | -80.0% |
| Q4 2014 | $1,599,000 | -9.9% | 46,945 | +2.1% | 0.01% | -16.7% |
| Q3 2014 | $1,774,000 | -0.9% | 45,991 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $1,790,000 | +14.6% | 45,991 | +0.7% | 0.01% | +20.0% |
| Q1 2014 | $1,562,000 | +63.0% | 45,674 | +0.0% | 0.01% | +66.7% |
| Q4 2013 | $958,000 | +104.3% | 45,667 | +129.1% | 0.00% | +50.0% |
| Q3 2013 | $469,000 | +7716.7% | 19,937 | +8568.3% | 0.00% | – |
| Q2 2013 | $6,000 | – | 230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |